Trichomonas Vaginalis

BD launches BD COR MX/PX infectious disease platform

By LabPulse.com staff writers

BD COR MX/PX integrates and automates the complete molecular laboratory workflow, from sample processing to diagnostic test results, for large, high-throughput labs, the company said.

May 12, 2022

Abbott’s STI test gets FDA nod

By LabPulse.com staff writers

The Alinity m STI test uses polymerase chain reaction (PCR) to detect Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium. The test requires one swab sample, or a urine sample collected in a healthcare setting, and it runs on Abbott's Alinity m molecular laboratory instrument.

May 3, 2022

DCN Dx acquires Biomed Diagnostics

By LabPulse.com staff writers

The purchase expands DCN Dx's reach into the point-of-use testing and sampling market by adding a number of tests to its portfolio, including InPouch TV for detection of Trichomonas vaginalis, Transport Media (VTM) for SARS-CoV-2 sample transport, and InTray VS COLOREX for testing for methicillin-resistant Staphylococcus aureus (MRSA).

April 24, 2022

Rheonix gets FDA nod for STI test, workstation

By LabPulse.com staff writers

The Encompass MDx workstation enables scalable, multiplexed sample-to-answer detection, simplifying laboratory workflows.

January 11, 2022

BD Cor system features MX instrument for infectious diseases

By LabPulse.com staff writers

The new instrument and its first test for sexually transmitted infections have received the CE Mark for IVD directive 98/79/EC.

December 16, 2021